Dear Friend,
You may have heard that the FDA recently approved a new medication for dyskinesia -- involuntary, irregular movement that can occur with long-term levodopa use for Parkinson's. (If not, check out the link below for more information.) To put this news in context, I thought it'd be helpful to explain what dyskinesia is, why it occurs and how it can be treated. Watch this "Ask the MD" video to learn about these topics and the ongoing research in dyskinesia.
The "Ask the MD" series translates Parkinson's science, research and medicine for you and your loved ones. I hope it helps you navigate life with the disease a little more easily. Visit the "Ask the MD" webpage and keep an eye out for blogs and videos in your email inbox.
You're a valued part of our community; thanks for your contributions.
Best,
Rachel Dolhun, MD
P.S. Read about extended-release amantadine (Gocovri).
Thank you to our Parkinson's disease Education Consortium members. While our generous sponsors make our educational offerings possible, their support does not influence MJFF's content or perspective. |
|
|
.png)
No hay comentarios:
Publicar un comentario